Moosburg, Germany

Hans-Juergen Christian

This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Pieris Pharmaceuticals Gmbh, Astrazeneca Ab, Pieris Ag. Active years: 2015-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Juergen Christian. Retrieved from https://idiyas.com/inventor/hans-juergen-christian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 60.0


 

Average Co-Inventor Count = 6.4

ph-index = 3

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Hans-Juergen Christian

Introduction

Hans-Juergen Christian, an accomplished inventor based in Moosburg, Germany, holds an impressive portfolio of five patents. His work primarily focuses on innovative applications within the field of biochemistry, particularly related to human tear lipocalin and its interactions with key receptors.

Latest Patents

Among his latest patents is a significant invention concerning "Tear lipocalin muteins binding IL-4 receptor alpha." This innovative development involves novel muteins derived from human tear lipocalin, which have a unique ability to bind to the IL-4 receptor alpha. The patent details specific combinations of amino acids that characterize these muteins, including mutated amino acid residues present at various sequence positions of the linear polypeptide. This invention not only brings forth the muteins but also provides corresponding nucleic acid molecules encoding such muteins and methodologies for their production.

Career Highlights

Throughout his career, Hans-Juergen has made substantial contributions while working with notable companies such as Pieris Pharmaceuticals GmbH and Pieris AG. His role in these organizations has been pivotal in the development of innovative therapeutic solutions that leverage his expertise in biochemistry and protein engineering.

Collaborations

Hans-Juergen has collaborated with distinguished professionals in the field, including Stefan Trentmann and Gabriele Matschiner. These collaborations have facilitated the exchange of ideas and fostered advancements in related scientific inquiries, thereby enhancing the impact of their work together.

Conclusion

In conclusion, Hans-Juergen Christian stands out as a prominent figure in the world of innovation and patents. His contributions to the field of tear lipocalin research and the development of novel muteins highlight the importance of inventors in advancing scientific understanding and creating potential therapeutic applications. With a solid foundation of patents and collaborative efforts, Hans-Juergen continues to inspire future innovations in biochemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…